Professional Activities:
Current Position: Arthur and Rosalie Kaplan Professor and Chair of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, Duarte, California, 2012-
Interim Deputy Director, Clinical Research, City of Hope Comprehensive Cancer Center (NCI-designated), 2012-2013
Previous Positions: Senior Staff Fellow: National Cancer Institute, Bethesda, Maryland, 20892, 1988-90.
- Assistant Professor of Medicine (7/90-12/95)
- Assistant Professor of Medicine and Pharmacology (7/92-12/95):
- Associate Professor of Pharmacology and Medicine (1/96-3/03).
- Columbia University, College of Physicians and Surgeons
- Professor of Medicine and Molecular Pharmacology
- Albert Einstein College of Medicine, Bronx, NY 10467
- Director, Medical Genitourinary Oncology
- Attending Physician
- Montefiore Medical Center, Bronx, NY 10467 (3/03-3/12)
- Diplomate, American Board of Internal Medicine, (1986)
- Diplomate, American Board of Oncology (1987)
Awards
American Cancer Society, Clinical Career Development Award (1992-1995)
Honors:
- Irving Assistant Professor of Medicine and Pharmacology, Columbia University (1993-1996)
- American Society for Clinical Investigation (1996)
- Who’s Who in America (Marquis, 2010-15)
- Who’s Who in the World (Marquis, 2011, 13-15)
- Top Doctors in the LA Area (Oncology), Pasadena Magazine 2013, 14
- Top Doctors in Los Angeles (Oncology), Hollywood Reporter 2014
- Best Doctors in New York, New York Magazine, 2008-9 (prostate cancer), 2011-12 (prostate and bladder cancer)
- New York’s “Superdoctors” (top 5%), New York Times Magazine, 2008-9
- Best Doctors in the NY Metro Area (2004-11), Castle Connolly Medical Ltd., publisher
- European Journal of Pharmaceutics and Biopharmaceutics, best paper of 1999 (2000)
- America’s Top Doctors for Cancer, Castle Connolly Medical Ltd. (2013, 14)
- Faculty of 1000 Biologists Selection (Nov., 2009; paper #116 in bibliography), cited as “exceptional”, with F1000 factor 9.0, 5th highest of all currently reviewed papers. Ranked #1 in “Hidden Jewels”
Co-Editor-in-Chief: Oligonucleotides 1993-2011 (formerly Antisense and Nucleic Acid Drug Development and Antisense Research and Development; Mary-Ann Liebert Publishers)
Series Editor: Perspectives in Antisense Science (Kluwer Academic Publishers; four volumes published)
Editorial Advisory Boards:
- Associate Editor: Cancer Gene Therapy (Stockton Press)
- Molecular Cancer Therapeutics (American Association for Cancer Research)
- Clinical Cancer Research (American Association for Cancer Research)
- Molecular Therapy (American Society for Gene Therapy)
Current Scientific Advisory Boards and Consultancies:
Santaris (Copenhagen, DK); Nanoviricides (West Haven, CT); iCeutica (King of Prussia, PA)
National PI: Phase III trial of Solumatrixabiraterone acetate + methylprednisolone vs. Abiraterone + prednisone (sponsored by iCeutica)
Former Consulting Chief Medical Officer, Tokai Pharmaceuticals (2009-10, Cambridge, MA) Lead compound, currently in a Phase 1/2 clinical trial is TOK-001 for castrate-resistant prostate cancer.
Professional Organizations:
- American Society for Clinical Oncology
- American Association for Cancer Research
- American Society for Gene Therapy (Oligonucleotide Therapeutics Committee, 2005-2008)